Make the Diagnosis: Veiled vision

(MedPage Today) — Case Study: An 85 year-old woman was admitted with COPD and was treated with bronchodilators, oral
glucocorticoids, antibiotics, and non-invasive ventilation for about 7 days. The patient’s family
states a new thin white film has ap…

Ocata Therapeutics Secures $10 Million in Debt Financing

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it has entered into a secured term loan facility of up to $10 million with Silicon Valley Bank. Ocata received initial funding of $6 million and has a conditional option to receive an additional $4 million upon the successful completion of certain clinical and corporate milestones. Ocata intends to use the proceeds for general corporate purpose